Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other



COMMODORE CAPITAL LP Create: Alert

All | News | Filings
Date FiledTypeDescription
10/12/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
10/06/2023 4 COMMODORE CAPITAL LP (10% Owner) has filed a Form 4 on Vistagen Therapeutics, Inc.
Txns: Granted 2,788,620 options to buy @ $0.001, valued at $2.8k
Granted 1,394,310 options to buy @ $5.38, valued at $7.5M
Granted 1,690,014 options to buy @ $8.877, valued at $15M
10/06/2023 SC 13G/A COMMODORE CAPITAL LP reports a 9.9% stake in Vistagen Therapeutics, Inc.
08/14/2023 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
08/09/2023 SC 13G COMMODORE CAPITAL LP reports a 19.7% stake in Vistagen Therapeutics, Inc.
08/09/2023 4 COMMODORE CAPITAL LP (10% Owner) has filed a Form 4 on Vistagen Therapeutics, Inc.
Txns: Bought 775,756 shares @ $23.153, valued at $18M
08/09/2023 3 COMMODORE CAPITAL LP (10% Owner) has filed a Form 3 on Vistagen Therapeutics, Inc.
04/27/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
04/24/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
04/20/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/28/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/27/2023 4 COMMODORE CAPITAL LP (10% Owner) has filed a Form 4 on Enliven Therapeutics, Inc.
Txns: Bought 622 shares @ $22.072, valued at $13.7k
Acquired 729,891 shares @ $0
02/23/2023 4 COMMODORE CAPITAL LP (10% Owner) has filed a Form 4 on IMARA Inc.
Txns: Bought 8,194 shares @ $5.249, valued at $43k
Bought 23,565 shares @ $5.113, valued at $120.5k
02/14/2023 SC 13G/A COMMODORE CAPITAL LP reports a 9.5% stake in Imara Inc.
02/14/2023 SC 13G/A COMMODORE CAPITAL LP reports a 1.7% stake in Karyopharm Therapeutics, Inc.
02/14/2023 SC 13G/A COMMODORE CAPITAL LP reports a 0% stake in VistaGen Therapeutics, Inc.
02/14/2023 SC 13G/A COMMODORE CAPITAL LP reports a 4.2% stake in BELLUS Health Inc.
02/14/2023 SC 13G/A COMMODORE CAPITAL LP reports a 6.8% stake in CymaBay Therapeutics, Inc.
02/14/2023 SC 13G/A COMMODORE CAPITAL LP reports a 6.3% stake in Immunic, Inc.
02/14/2023 SC 13G/A COMMODORE CAPITAL LP reports a 9.9% stake in Celcuity Inc.
02/14/2023 SC 13G/A COMMODORE CAPITAL LP reports a 5.9% stake in Merus N.V.
02/14/2023 SC 13G/A COMMODORE CAPITAL LP reports a 7% stake in Cogent Biosciences, Inc.
02/14/2023 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
01/13/2023 SC 13G COMMODORE CAPITAL LP reports a 5% stake in Cabaletta Bio, Inc.
11/16/2022 SC 13G/A COMMODORE CAPITAL LP reports a 0% stake in Satsuma Pharmaceuticals, Inc.
11/16/2022 4 COMMODORE CAPITAL LP (10% Owner) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.
Txns: Sold 3,250,000 shares @ $0.706, valued at $2.3M
10/24/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
10/21/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
08/15/2022 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
05/19/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
05/16/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
05/16/2022 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
05/09/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
04/14/2022 SC 13G COMMODORE CAPITAL LP reports a 5.1% stake in VistaGen Therapeutics, Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy